Shuttle Pharmaceuticals Holdings Inc
Research Shuttle Pharmaceuticals Holdings Inc (SHPH) on Bullrun: market cap USD 1.91M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSHPH
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- CurrencyUSD
- Market capUSD 1.91M
- Financial periodQ1 2026
- RevenueUSD 0
- Net income-USD 10.82M
- Free cash flow-USD 2.45M
Valuation Snapshot
latest market cap is USD 1.91M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 0 | -USD 11.72M | -USD 12.54M | n/a | -7.16 | USD 334.01K | USD 232.15K | USD 2.25M |
| FY2024 | USD 0 | -USD 9.14M | -USD 7.33M | n/a | -82.6 | USD 1.92M | USD 1.17M | USD 709.15K |
| FY2023 | n/a | -USD 6.59M | -USD 5.60M | n/a | -3.53 | USD 2.58M | USD 1.09M | USD 4.06M |
| FY2022 | n/a | -USD 5.00M | n/a | n/a | -5.04 | USD 8.42M | USD 1.36M | USD 7.68M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 1.91M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 19.77M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 87.57M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 181.99M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 662.83M | n/a | n/a | n/a |
About Shuttle Pharmaceuticals Holdings Inc
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Shuttle Pharmaceuticals Holdings Inc's market cap?
Shuttle Pharmaceuticals Holdings Inc's market capitalization is USD 1.91M.
What does Shuttle Pharmaceuticals Holdings Inc do?
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.